4-(4,9-dimethyl-10H-indolo[3,2-b]quinolin-11-yl)-N-(2-(dimethylamino)ethyl)benzamide

ID: ALA1760431

PubChem CID: 54580017

Max Phase: Preclinical

Molecular Formula: C28H28N4O

Molecular Weight: 436.56

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc2c(-c3ccc(C(=O)NCCN(C)C)cc3)c3[nH]c4c(C)cccc4c3nc12

Standard InChI:  InChI=1S/C28H28N4O/c1-17-7-5-9-21-23(19-11-13-20(14-12-19)28(33)29-15-16-32(3)4)27-26(30-24(17)21)22-10-6-8-18(2)25(22)31-27/h5-14,31H,15-16H2,1-4H3,(H,29,33)

Standard InChI Key:  FAQPUFKBONNWDR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   -3.0653   -6.4240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3290   -7.2082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7826   -7.8264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2596   -6.2585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7117   -6.8735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9738   -7.6570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3098   -8.1484    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8857   -6.8808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6400   -7.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1618   -7.8454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330   -6.2767    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4089   -8.6280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1510   -9.2354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0955  -10.0219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9015  -10.2022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4605   -9.5897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2111   -8.8055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4682   -6.4518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7158   -7.2426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5228   -7.4222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0830   -6.8118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8306   -6.0193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0242   -5.8434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1518  -10.9916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5946  -11.5998    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9573  -11.1700    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0424   -8.6094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7743   -5.0572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2109  -11.4213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4590  -10.6345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2645  -10.4559    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5125   -9.6692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8218  -11.0642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  7  9  1  0
 15 16  1  0
  8  5  1  0
 16 17  2  0
 17 12  1  0
 10 12  1  0
  1  2  2  0
  5  4  2  0
 18 19  1  0
  8  9  2  0
 19 20  1  0
  4  1  1  0
 20 21  2  0
  9 10  1  0
 21 22  1  0
 10 19  2  0
 22 23  2  0
 23 18  1  0
  5  6  1  0
 18 11  2  0
 11  8  1  0
 24 25  1  0
 24 26  2  0
 15 24  1  0
  3 27  1  0
  2  3  1  0
 23 28  1  0
 12 13  2  0
 25 29  1  0
  3  6  2  0
 29 30  1  0
 13 14  1  0
 30 31  1  0
  6  7  1  0
 31 32  1  0
 14 15  2  0
 31 33  1  0
M  END

Associated Targets(Human)

5637 (630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RT-4 (268 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-427 (643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DAN-G (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 436.56Molecular Weight (Monoisotopic): 436.2263AlogP: 5.44#Rotatable Bonds: 5
Polar Surface Area: 61.02Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.92CX Basic pKa: 8.51CX LogP: 5.40CX LogD: 4.26
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.39Np Likeness Score: -0.78

References

1. Riechert-Krause F, Eick A, Grünert R, Bednarski PJ, Weisz K..  (2011)  In vitro anticancer activity and evaluation of DNA duplex binding affinity of phenyl-substituted indoloquinolines.,  21  (8): [PMID:21414783] [10.1016/j.bmcl.2011.02.088]

Source